Delivery Order SPE2DR25D6028-SPE2DR26FASEK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Levophed (norepinephrine) in 4 milliliter vials, quantity 10, with a ceiling value of $3,567.04 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Levophed (norepinephrine) in 4-milliliter vials, quantity 10, with a ceiling value of $1,026.68. The contract employs firm fixed price pricing and carries an ultimate completion date of August 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,802.12 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Levophed (norepinephrine) in 4ml vials, a critical vasopressor medication used in emergency and intensive care settings. This firm fixed-price delivery order, with a completion date of September 29, 2025, was competitively awarded without set-aside designation and will be performed at the contractor's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $4,836.36, for the supply of Levophed (norepinephrine) in 4ml vials, 10-count packages. This firm fixed-price delivery order, with an ultimate completion date of January 5, 2026, was competitively awarded without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,082.00 to AmerisourceBergen Drug Corp for Levophed SDV 4ML in quantities of 10 units. This non-competed delivery order, issued on October 22, 2025, with completion scheduled for October 23, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,680.66 to AmerisourceBergen Drug Corp for Levophed SDV (single-dose vials) 4ML in quantities of 10 units, with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order, awarded on October 27, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for Levophed 4 mg/4 mL vials with a ceiling value of $1,334.19. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for Levophed SDV 4ML in quantities of 10, with a ceiling value of $3,076.85. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $1,756.64 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Norepinephrine 4 mg/4 mL vials (4 mL quantity). This firm fixed-price contract represents a non-competitive set-aside and will be performed at the vendor's location in Conshohocken, Pennsylvania, with a completion deadline of December 4, 2025. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,783.99 to AmerisourceBergen Drug Corp for the supply of Norepinephrine 4 mg/4 mL vials on December 12, 2025, with a completion deadline of December 15, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASEKDelivery Order
The Defense Logistics Agency awarded a $4,935.52 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Levophed (norepinephrine) intravenous solution in 4ml vials, quantity 10 units. This is a firm fixed price, non-set-aside order with performance in Conshohocken, Pennsylvania, scheduled for completion by December 30, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The company's SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Levophed, a critical vasopressor medication used in emergency and intensive care settings, reflects the company's ongoing role in supplying essential pharmaceutical products to Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 12/1/25 |